ADC抗體內(nèi)吞檢測試劑

抗體內(nèi)化,也可以理解為抗體內(nèi)吞,是指在細胞表面的抗體與相應(yīng)的抗原結(jié)合后,通過自身分子運輸體系,將抗體和抗原復(fù)合物帶入細胞內(nèi)部,并在內(nèi)部起到特定的生物學(xué)作用??贵w內(nèi)化是大多數(shù)抗體偶聯(lián)藥物(Antibody-drug conjugates,ADC)分子進入細胞的方式。常規(guī)內(nèi)吞作用可分為三個階段:芽形成;膜彎曲和囊泡成熟;以及膜分裂并釋放到細胞質(zhì)中。更多關(guān)于抗體內(nèi)吞原理>>

ADC主要由單克隆抗體、連接子和細胞毒素(又稱為有效載荷或Payload)三部分構(gòu)成。其中抗體作為ADC藥物的“導(dǎo)彈”,具有靶向功能,可以特異性識別腫瘤細胞表面抗原,與細胞表面抗原結(jié)合后發(fā)生內(nèi)吞,將細胞毒素帶到腫瘤細胞并發(fā)揮毒性效應(yīng)。由于一些抗體與抗原結(jié)合后不一定會被靶細胞內(nèi)吞,所以抗體內(nèi)化能力是ADC藥物早期篩選的一項重要指標(biāo)。

締碼生物已開發(fā)出兩種抗體內(nèi)吞檢測試劑,兼具高靈敏度、穩(wěn)定性、成本效益及廣泛的IgG亞型兼容性。

  • pH敏感型IgG標(biāo)記試劑:利用pH敏感熒光標(biāo)記的Fc結(jié)合蛋白與不同物種的IgG抗體結(jié)合,形成熒光復(fù)合物。抗體被細胞內(nèi)吞后,酸性環(huán)境會增強熒光信號,其強度可直接反映內(nèi)吞效率。
  • 載荷偶聯(lián)型IgG標(biāo)記試劑:通過將常用的ADC藥物載荷偶聯(lián)至IgG分子,模擬ADC機制,實現(xiàn)抗體內(nèi)吞檢測與細胞毒性評估的結(jié)合。

案例展示

DiTag? pH-sensitive IgG labeling reagents offer a convenient way to measure antibody internalization. These reagents use a pH-sensitive fluorescent dye conjugated Fc binding protein, which forms a complex with IgG antibodies. Upon internalization, the acidic environment enhances the fluorescence signal, indicating internalization activity. By measuring fluorescence intensity, researchers can assess internalization efficiency and gain insights into antibody uptake mechanisms, helping optimize antibody-based therapies and drug delivery systems.

The fluorescent signal from GPRC5D ADC BMK-AME100002 conjugate is only detected in GPRC5D positive cells (K562-GPRC5D stable expression cell line) and not in parental K562 cells, indicating specific internalization.

Comparison of internalization efficiency between AME100002 and a competitor reagent on GPRC5D-positive cells (K562-GPRC5D stable expression cell line). AME100002 requires less reagent and shorter incubation time while demonstrating higher sensitivity. It is the most cost-effective pH-sensitive fluorescence IgG labeling reagent available. This pH-sensitive IgG labeling reagent is compatible with human IgG1, IgG2, IgG3, IgG4, rabbit IgG, and mouse IgG subtypes (IgG1, IgG2a, IgG2b, IgG3).

Payload-conjugated IgG labeling reagents use a payload-conjugated Fc binding protein to label various IgG antibodies. Once the IgG-payload complex is added to the cells, the cell inhibition rate for each sample is determined using the CCK8 method. This approach mimics the real ADC mechanism, where the antibody delivers the payload into the cells, resulting in cell death. By measuring the cell inhibition, researchers can evaluate the effectiveness of the candidate mAbs and gain insights into the potential of ADCs for therapeutic applications.

Cell inhibition rate of HeLa cells detected using the CCK8 method. B7H3 ADC BMK was mixed with DiTag? MMAE IgG labeling reagent (Cat. No. AME100003) to form a complex, which was applied to HeLa cells for the inhibition test. The results were compared to the control, where Isotype Control IgG was mixed with AME100003 and applied to the cells. The IC50 of B7H3 ADC BMK is 66 ng/ml.

Accelerated stability test of AME100003. Following lyophilization, samples were stored at -20°C (black), 37°C for 1 day (red), 37°C for 2 days (blue), and 37°C for 3 days (green), separately. Upon reconstitution, the cell inhibition rate of each sample was determined using the CCK8 method. The data indicate excellent stability for all samples.

產(chǎn)品列表

SKU:  AME100005

Application:  Antibody internalization labeling kit

Price: 10μg ¥2060.00 ; 50μg ¥6170.00 ; 100 μg ¥7400.00

SKU:  AME100003

Application:  Antibody internalization labeling reagent

Price: 10μg ¥1920.00 ; 50μg ¥5750.00 ; 100 μg ¥6900.00

SKU:  AME100002

Application:  Antibody internalization labeling reagent

Price: 10μg ¥4418.00 ; 50μg ¥13215.00 ; 100 μg ¥15858.00

SKU:  AME100001

Application:  Antibody internalization labeling reagent

Price: 10μg ¥4418.00 ; 50μg ¥13215.00 ; 100 μg ¥15858.00